All ISTAT Online recordings are available for members of the commercial aviation industry. Below, you will find all previously aired ISTAT Chats and ISTAT Learning Labs for on demand viewing.
ISTAT Podcast S03 EP01
Featuring Gerry Butler, ISTAT President and Chief Marketing Officer at Merx Aviation Finance
Aired On: 09 December 2020
Gerry Butler shares his interesting background, his achievements as ISTAT president and his view on the pandemic, including his concerns of its effect on mental health.
ISTAT Rising Executives Online Event - 19 November 2020
Featuring Paul Geaney, Head of OEM Team, Avolon and Karl Griffin, Chief Commercial & Investment Officer, Genesis
Aired On: 19 November 2020
Two of the industry's intriguing leaders share their experiences being young professionals during the 2008 Great Recession. Hear their lessons learned and advice for navigating the challenges aviation professionals currently face.
ISTAT Podcast S02 EP04
Featuring Jeff Straebler, Executive Director of the ISTAT Appraisers Program (IAP)
Aired On: 18 November 2020
Jeff Straebler, Executive Director of the ISTAT Appraisers Program (IAP) talks about his background, where his career in aviation began and how his previous jobs prepared him for his current role.
ISTAT Podcast S02 EP03
Featuring ISTAT Certified Senior Appraiser Oliver Stuart-Menteth
ISTAT Certified Senior Appraiser Oliver Stuart-Menteth, Managing Director, Fintech Aviation Services SARL shares how his experiences in Hong Kong at a young age influenced his path into the industry.
ISTAT Learning Lab: Airline Restructurings During COVID-19
Featuring Douglas Walker, Managing Director, Seabury Capital
Aired On: 17 November 2020
This session provides a comprehensive overview of the restructurings that have taken place during the pandemic thus far.
ISTAT Podcast S02 EP02
Featuring ISTAT Certified Senior Appraiser Stuart Hatcher
Aired On: 06 November 2020
Stuart Hatcher, ISTAT Certified Senior Appraiser, Chief Revenue Officer, IBA Group, Ltd. discusses his interesting background as a drug designer in the pharmaceutical industry.